Institutional members access full text with Ovid®

Share this article on:

The Sooner, the Better: Early Beta-Blocker Administration in Patients With ST-Elevation Myocardial Infarction*

Roolvink, Vincent MD; van‘t Hof, Arnoud W. J. MD, PhD; van der Horst, Iwan C. C. MD, PhD

doi: 10.1097/CCM.0b013e318283ce8b
Editorials

Department of CardiologyIsala KliniekenZwolle, The Netherlands

Department of Critical CareUniversity of GroningenUniversity Medical Center GroningenGroningen, The Netherlands

*See also p. 1396.

Dr. van’t Hof has board membership with Astra Zeneca, Eli-Lilly, and the Medicines Company. Dr. van’t Hof consults for Iroko Cardio. Dr. van’t Hof received grant support from Medtronic, Merck, Abbott, Eli Lilly, Pfizer, and the Medicines Company. Dr. van’t Hof lectured for Merck Sharpe Dohme and Iroko Cardio.

The remaining authors have disclosed that they do not have any potential conflicts of interest.

© 2013 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins